Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Accumulate on Pullback
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Hi Tech Pharmacal (NASDAQ: HITK) price target of $45.00.
Analyst, Randall Stanicky, said, "YTD performance (down -18%) and attractive valuation (4.5x EV/EBITDA on fiscal 2014E) have created a pick-up in interest in the stock. Upcoming fiscal Q4 EPS (week of July 9) could see pressure on a combination of lower cough and cold and higher near-term SG&A spending (we recently cut EPS to $0.73 from prior $0.81). Street EPS has remained largely static (consensus at $0.78) since early March, creating what could be a tougher set-up. Absent something unforeseen from results, we think a pull-back on results could create a buying opportunity on an attractive high barrier generic asset we continue to like into fiscal 2013."
For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.
Shares of Hi Tech Pharmacal closed at $32.09 yesterday.
Analyst, Randall Stanicky, said, "YTD performance (down -18%) and attractive valuation (4.5x EV/EBITDA on fiscal 2014E) have created a pick-up in interest in the stock. Upcoming fiscal Q4 EPS (week of July 9) could see pressure on a combination of lower cough and cold and higher near-term SG&A spending (we recently cut EPS to $0.73 from prior $0.81). Street EPS has remained largely static (consensus at $0.78) since early March, creating what could be a tougher set-up. Absent something unforeseen from results, we think a pull-back on results could create a buying opportunity on an attractive high barrier generic asset we continue to like into fiscal 2013."
For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.
Shares of Hi Tech Pharmacal closed at $32.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Idex Corp. (IEX) Reiterated at Buy by Stifel
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- DA Davidson Starts Everus (ECG) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
